Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (71-80 of 533) with videos related to

Pageof 54
Sort By:
Research Square|May 3, 2023
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement systemAlexander Bukreyev, Philipp Ilinykh, Kai Huang, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 5, 2012
Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cellsYvonne J Yamanaka, Christoph T Berger, Magdalena Sips, et al.
Vaccine|March 1, 2020
Maternal determinants of infant immunity: Implications for effective immunization and maternal-child healthMarcela F Pasetti, Margaret E Ackerman, Annie G Hoen, et al.
Molecular & Cellular Proteomics : MCP|January 20, 2019
Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific <i>N</i>-Glycosylation ProfilesKevin Brown Chandler, Nickita Mehta, Deborah R Leon, et al.
Journal of Visualized Experiments : Jove|December 7, 2011
Determining the phagocytic activity of clinical antibody samplesElizabeth G McAndrew, Anne-Sophie Dugast, Anna F Licht, et al.
The Journal of Clinical Investigation|May 5, 2010
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionGalit Alter, Daniel Kavanagh, Suzannah Rihn, et al.
The Journal of Clinical Investigation|December 18, 2019
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccinationCarolyn M Boudreau, Wen-Han Yu, Todd J Suscovich, et al.
Journal of Immunological Methods|July 14, 2019
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activationStephanie Fischinger, Jonathan K Fallon, Ashlin R Michell, et al.
AIDS (London, England)|December 4, 2004
Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infectionGalit Alter, Christos Micheal Tsoukas, Danielle Rouleau, et al.
European Journal of Epidemiology|February 4, 2023
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategiesAnna L Beukenhorst, Clarissa M Koch, Christoforos Hadjichrysanthou, et al.
Pageof 54

Showing results (71-80 of 533) with videos related to

Sort By:
Pageof 54
Research Square|May 3, 2023
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement systemAlexander Bukreyev, Philipp Ilinykh, Kai Huang, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|September 5, 2012
Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cellsYvonne J Yamanaka, Christoph T Berger, Magdalena Sips, et al.
Vaccine|March 1, 2020
Maternal determinants of infant immunity: Implications for effective immunization and maternal-child healthMarcela F Pasetti, Margaret E Ackerman, Annie G Hoen, et al.
Molecular & Cellular Proteomics : MCP|January 20, 2019
Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific <i>N</i>-Glycosylation ProfilesKevin Brown Chandler, Nickita Mehta, Deborah R Leon, et al.
Journal of Visualized Experiments : Jove|December 7, 2011
Determining the phagocytic activity of clinical antibody samplesElizabeth G McAndrew, Anne-Sophie Dugast, Anna F Licht, et al.
The Journal of Clinical Investigation|May 5, 2010
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionGalit Alter, Daniel Kavanagh, Suzannah Rihn, et al.
The Journal of Clinical Investigation|December 18, 2019
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccinationCarolyn M Boudreau, Wen-Han Yu, Todd J Suscovich, et al.
Journal of Immunological Methods|July 14, 2019
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activationStephanie Fischinger, Jonathan K Fallon, Ashlin R Michell, et al.
AIDS (London, England)|December 4, 2004
Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infectionGalit Alter, Christos Micheal Tsoukas, Danielle Rouleau, et al.
European Journal of Epidemiology|February 4, 2023
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategiesAnna L Beukenhorst, Clarissa M Koch, Christoforos Hadjichrysanthou, et al.
Pageof 54